查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632598

全球醫療設備電極市場：市場規模、佔有率和趨勢分析（按類型、地區和細分，2025-2030 年）

Electrodes For Medical Devices Market Size, Share & Trends Analysis Report By Type (Diagnostics (Electrocardiogram, Electroencephalogram, Electromyogram), Therapeutics), By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

醫療設備電極市場的成長與趨勢：

根據 Grand View Research 的新報告，到 2030 年全球醫療設備電極市場規模預計將達到 27 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 6.5%。由於心臟病、帕金森氏症 (PD)、阿茲海默症症、纖維肌痛、循環系統疾病、痛風、身體疼痛和其他疾病等慢性疾病在全球範圍內的發病率不斷上升，預計預測期內市場將呈現良好成長。

微創手術 (MIS) 是醫療技術的一項進步，涉及在身體上做小切口以進行腹腔鏡、內視鏡、關節鏡和其他外科手術。此手術因恢復快、術後感染疾病少、疼痛少、出血少、疤痕少、準確度高等優點而廣受歡迎。 2015 年，超過 2000 萬美國接受了 MIS，預計這將在預測期內促進該行業的發展。

醫療設備電極市場：分析概述

  • 診斷領域將在 2024 年佔據市場主導地位。在過去幾年中，心血管、神經和睡眠障礙的發生率增加，導致全球範圍內進行的診斷程序數量增加。
  • 心臟病、胎兒窘迫症候群、眼科疾病和神經系統疾病的盛行率不斷上升，導致心電圖 (ECG)、腦電圖 (EEG)、電外科手術和胎兒頭皮電極的廣泛使用。
  • 預計在預測期內，治療領域將以最快的複合年成長率成長。治療領域進一步分為心律調節器、經皮神經刺激設備(TENS)、心臟去顫器、電外科手術等。
  • 預計在預測期內，心臟去顫器和電外科電極將佔據相當大的市場佔有率。這是由於穿戴心臟去顫器可以持續監測佩戴者的心律，識別任何異常，通知用戶，並恢復正常的心臟功能。
  • 2024 年，北美將佔據最大的收益佔有率，達到 42.8%，這得益於該地區心血管疾病患病率的不斷上升、個人生活方式的改變、人們健康意識的增強以及美國和加拿大的目標市場。
  • 預計預測期內亞太地區將以最快的速度成長，複合年成長率為 12.7%。這是由於該地區存在慢性病、政府提高了健康意識以及醫療保健領域的投資激增。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章醫療設備電極市場：因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 醫療設備電極市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第4章醫療設備電極市場：按類型進行評估與趨勢分析

  • 全球醫療設備電極市場：按類型分類的儀表板
  • 全球醫療設備電極市場：按類型波動分析
  • 全球醫療設備電極市場按類型分類（以收益為準）
  • 診斷
    • 心電圖 (ECG)
    • 腦電圖 (EEG)
    • 肌電圖 (EMG)
    • 視網膜電圖 (ERG)
    • 胎兒頭皮
    • 其他
  • 治療
    • 心律調節器
    • 經皮電神經刺激設備
    • 心臟去顫器
    • 電外科
    • 其他

第 5 章醫療設備電極市場：按地區分類的估計和趨勢分析

  • 區域控制面板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業市場佔有率分析（2024年）
    • 3M
    • Boston Scientific Corporation
    • GE Healthcare
    • CONMED Corporation
    • Medtronic
    • Natus Medical Incorporated
    • Thermo Fisher Scientific Inc.
    • Koninklijke Philips NV
    • X-trodes
Product Code: GVR-1-68038-913-5

Electrodes For Medical Devices Market Growth & Trends:

The global electrodes for medical devices market size is anticipated to reach USD 2.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.5% from 2025 to 2030. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson's Disease (PD), Alzheimer's disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe.

Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.

Electrodes For Medical Devices Market Report Highlights:

  • The diagnostics segment dominated the market in 2024. There has been an increase in the number of cardiovascular, neurological, and sleep disorders in the last few years, which has led to an increase in the number of diagnostics procedures being carried out around the world.
  • Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
  • The therapeutics segment is expected to grow at the fastest CAGR during the forecasted period. The therapeutics segment is further classified into pacemakers, Transcutaneous Electrical Nerve Stimulators (TENS), defibrillators, electrosurgical, and others.
  • Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
  • North America held the largest revenue share of 42.8% in 2024 due to the increasing prevalence of CVD in the region, the changing lifestyle of individuals, health awareness among people, and the presence of the target audience in the U.S. and Canada.
  • Asia Pacific is expected to grow at the fastest CAGR of 12.7% over the forecast period. This can be attributed to the presence of chronic diseases in the region, government initiatives regarding health awareness & surge in investment in the healthcare sector.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type scope
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Electrodes For Medical Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for minimally invasive procedures.
      • 3.2.1.2. Rising prevalence of chronic cardiovascular diseases
      • 3.2.1.3. Technological advancements in electrode materials and designs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced electrodes and devices
      • 3.2.2.2. Stringent regulatory approval processes, delaying product launches
  • 3.3. Electrodes For Medical Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Electrodes For Medical Devices Market: Type Estimates & Trend Analysis

  • 4.1. Global Electrodes For Medical Devices Market: Type Dashboard
  • 4.2. Global Electrodes For Medical Devices Market: Type Movement Analysis
  • 4.3. Global Electrodes For Medical Devices Market by Type, Revenue
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Electrocardiogram (ECG)
      • 4.4.2.1. Electrocardiogram (ECG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Electroencephalogram (EEG)
      • 4.4.3.1. Electroencephalogram (EEG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Electromyogram (EMG)
      • 4.4.4.1. Electromyogram (EMG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Electroretinogram (ERG)
      • 4.4.5.1. Electroretinogram (ERG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Fetal Scalp
      • 4.4.6.1. Fetal scalp market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Pacemaker
      • 4.5.2.1. Pacemaker market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Transcutaneous electrical nerve stimulator
      • 4.5.3.1. Transcutaneous electrical nerve stimulator market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Defibrillator
      • 4.5.4.1. Defibrillator market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Electrosurgical
      • 4.5.5.1. Electrosurgical market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrodes For Medical Devices Market: Regional Estimates & Trend Analysis by Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. Key company market share analysis, 2024
    • 6.2.2. 3M
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. GE Healthcare
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. CONMED Corporation
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Natus Medical Incorporated
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Thermo Fisher Scientific Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Koninklijke Philips N.V.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. X-trodes
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 6 Mexico electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 Germany electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 10 UK electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 France electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 Italy electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 13 Spain electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Denmark electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 15 Sweden electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Norway electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 19 China electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 Japan electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 21 India electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 South Korea electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 23 Australia electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Thailand electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 Latin America electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 27 Brazil electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 29 MEA electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 South Africa electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait electrodes for medical devices market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Electrodes for medical devices market: market outlook
  • Fig. 7 Electrodes for medical devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Electrodes for medical devices market driver impact
  • Fig. 11 Electrodes for medical devices market restraint impact
  • Fig. 12 Electrodes for medical devices market: Type movement analysis
  • Fig. 13 Electrodes for medical devices market: Type outlook and key takeaways
  • Fig. 14 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Electrocardiogram (ECG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Electroencephalogram (EEG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Electromyogram (EMG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Electroretinogram (ERG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Fetal scalp market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Pacemaker market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Transcutaneous electrical nerve stimulator (TENS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Defibrillator market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Electrosurgical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global electrodes for medical devices market: Regional movement analysis
  • Fig. 28 Global electrodes for medical devices market: Regional outlook and key takeaways
  • Fig. 29 Global electrodes for medical devices market share and leading players
  • Fig. 30 North America, by country
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. key country dynamics
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada key country dynamics
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico key country dynamics
  • Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK key country dynamics
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany key country dynamics
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 France key country dynamics
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy key country dynamics
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain key country dynamics
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark key country dynamics
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden key country dynamics
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway key country dynamics
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China key country dynamics
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India key country dynamics
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand key country dynamics
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea key country dynamics
  • Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil key country dynamics
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina key country dynamics
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa key country dynamics
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia key country dynamics
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 UAE key country dynamics
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait key country dynamics
  • Fig. 81 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Market share of key market players- Electrodes for medical devices market